AtriCure
ATRC
197 hedge funds and large institutions have $1.16B invested in AtriCure in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 101 increasing their positions, 52 reducing their positions, and 52 closing their positions.
94% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 52
59% more call options, than puts
Call options by funds: $2.94M | Put options by funds: $1.85M
0.55% more ownership
Funds ownership: 104.35% → 104.9% (+0.55%)
12% less funds holding
Funds holding: 224 → 197 (-27)
23% less capital invested
Capital invested by funds: $1.51B → $1.16B (-$353M)
50% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$41M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$17.6M |
| 3 |
Millennium Management
New York
|
+$13.7M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$13.5M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$26M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$24.6M |
| 3 |
FAM
Fred Alger Management
New York
|
-$17M |
| 4 |
Morgan Stanley
New York
|
-$13.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$11.8M |
ATRC Hedge Fund Activity: Q2 2024 in Review
197 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2024, worth a combined $1.16B — down 23% from $1.51B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of ATRC and 26 opened new positions — a net loss of 26 holders — while 52 trimmed existing stakes and 101 added.
The largest buyer was Hood River Capital Management, opening a new position worth an estimated $41M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $26M sold.
- 197 institutional investors held AtriCure (ATRC) as of Q2 2024, down from 224 in Q1 2024.
- Funds reported $1.16B of AtriCure stock for Q2 2024, down 23% quarter-over-quarter.
- 26 funds opened new AtriCure positions in Q2 2024 and 52 closed out, a net change of -26 holders.
- The largest AtriCure buyer in Q2 2024 was Hood River Capital Management, an estimated $41M added.
- The largest AtriCure seller in Q2 2024 was TimesSquare Capital Management, an estimated $26M sold.
Based on aggregated 13F filings for Q2 2024.